| Single-particle cryo-EM at atomic resolution T Nakane, A Kotecha, A Sente, G McMullan, S Masiulis, PMGE Brown, ... Nature 587 (7832), 152-156, 2020 | 705 | 2020 |
| GABAA receptor signalling mechanisms revealed by structural pharmacology S Masiulis, R Desai, T Uchański, I Serna Martin, D Laverty, D Karia, ... Nature 565 (7740), 454-459, 2019 | 480 | 2019 |
| Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer D Laverty, R Desai, T Uchański, S Masiulis, WJ Stec, T Malinauskas, ... Nature 565 (7740), 516-520, 2019 | 298 | 2019 |
| Megabodies expand the nanobody toolkit for protein structure determination by single-particle cryo-EM T Uchański, S Masiulis, B Fischer, V Kalichuk, U López-Sánchez, ... Nature methods 18 (1), 60-68, 2021 | 100 | 2021 |
| An improved yeast surface display platform for the screening of nanobody immune libraries T Uchański, T Zögg, J Yin, D Yuan, A Wohlkönig, B Fischer, ... Scientific reports 9 (1), 382, 2019 | 83 | 2019 |
| Nanobodies to study protein conformational states T Uchański, E Pardon, J Steyaert Current opinion in structural biology 60, 117-123, 2020 | 73 | 2020 |
| Conformational transitions and ligand-binding to a muscle-type nicotinic acetylcholine receptor E Zarkadas, E Pebay-Peyroula, MJ Thompson, G Schoehn, T Uchański, ... Neuron 110 (8), 1358-1370. e5, 2022 | 44 | 2022 |
| CXCL10 is an agonist of the CC family chemokine scavenger receptor ACKR2/D6 A Chevigné, B Janji, M Meyrath, N Reynders, G D’uonnolo, T Uchański, ... Cancers 13 (5), 1054, 2021 | 29 | 2021 |
| Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22 M Meyrath, N Reynders, T Uchański, A Chevigné, M Szpakowska Journal of Leucocyte Biology 109 (2), 373-376, 2021 | 22 | 2021 |
| A new expression vector facilitating production and functional analysis of scFv antibody fragments selected from Tomlinson I+ J phagemid libraries K Ossysek, T Uchański, M Kulesza, M Bzowska, T Klaus, K Woś, M Madej, ... Immunology Letters 167 (2), 95-102, 2015 | 18 | 2015 |
| An improved yeast surface display platform for the screening of nanobody immune libraries. Sci Rep 9 (1): 382 T Uchanski, T Zogg, J Yin, D Yuan, A Wohlkonig, B Fischer, ... | 9 | 2019 |
| Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors R Luís, G D’Uonnolo, CB Palmer, M Meyrath, T Uchański, M Wantz, ... Methods in Cell Biology 169, 279-294, 2022 | 8 | 2022 |
| Rapid discovery and characterization of synthetic neutralizing antibodies against anthrax edema toxin M Farcasanu, AG Wang, T Uchański, LJ Bailey, J Yue, Z Chen, X Wu, ... Biochemistry 58 (27), 2996-3004, 2019 | 6 | 2019 |
| The extended n-terminal domain confers atypical chemokine receptor properties to Cxcr3-b G D’Uonnolo, N Reynders, M Meyrath, D Abboud, T Uchański, ... Frontiers in Immunology 13, 868579, 2022 | 5 | 2022 |
| Nanoluciferase-based complementation assay for systematic profiling of GPCR–GRK interactions CB Palmer, G D'Uonnolo, R Luís, M Meyrath, T Uchański, A Chevigné, ... Methods in Cell Biology 169, 309-321, 2022 | 5 | 2022 |
| ChILL & DisCO to discover competitive, connective and allosteric Nanobodies that modulate the SOS1· RAS protein-protein interactions and tune the nucleotide exchange rate B Fischer, T Uchanski, A Sheryazdanova, S Gonzalez, A Volkov, ... bioRxiv 10 (2022.12), 06.519258, 2022 | 2 | 2022 |
| Constructing and purifying megabodies starting from individual nanobody sequences T Uchański, B Fischer, V Kalichuk, A Wohlkönig, T Zögg, E Pardon, ... | 1 | 2021 |
| Antigen-binding chimeric proteins and methods and uses thereof J Steyaert, E Pardon, T Uchanski, W Vranken US Patent 11,873,347, 2024 | | 2024 |
| Rapid small-scale nanobody-assisted purification of ryanodine receptors for cryo-EM C Li, K Willegems, T Uchanski, E Pardon, J Steyaert, RG Efremov bioRxiv, 2024.04. 03.587959, 2024 | | 2024 |
| Nanodisc-specific antigen-binding chimeric proteins J Steyaert, T Uchanski, S Masiulis, AR Aricescu US Patent App. 17/770,776, 2022 | | 2022 |
